secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001140361-25-006659
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Grace Therapeutics updates corporate presentation with cash and runway guidance
-------------------------------------------------------------------------------

- Corporate presentation updated as of March 3, 2025; includes cash position and runway guidance.
- No specific financial figures (e.g., cash balance, runway duration) are available in the filing excerpt.
- Presentation furnished as Exhibit 99.1; further detail not disclosed in the 8-K text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000114036125006659/0001140361-25-006659-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000114036125006659/ef20044669_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-006659

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer